Status:
COMPLETED
The Genetic Basis for Vulnerability to Substance Abuse
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Substance Abuse
Eligibility:
All Genders
18+ years
Brief Summary
This investigation seeks to better define the genetic basis for vulnerability to substance abuse.
Detailed Description
Dopamine (DA), a neurotransmitter helping to mediate reward and reinforcement, has been putatively linked to the development of substance abuse, alcohol abuse, and alcoholism. Identification of specif...
Eligibility Criteria
Inclusion
- Substance abusers
- Allow for blood draw
Exclusion
- Cognitively impaired
Key Trial Info
Start Date :
August 1 1992
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2006
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT00247819
Start Date
August 1 1992
End Date
February 1 2006
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute on Drug Abuse
Baltimore, Maryland, United States, 21224